LIAN - LianBio assigns rights for NBTXR3 in China and more Asian markets
2023-12-26 03:50:07 ET
More on LianBio
- LianBio confirms buyout offer from Concentra Biosciences
- LianBio receives buyout offer of $4.30 per share, plus CVR
- Financial information for LianBio
For further details see:
LianBio assigns rights for NBTXR3 in China and more Asian markets